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ABSTRACT
Worldwide, more than 3 million children are infected
with HIV and, without treatment, mortality among these
children is extremely high. Both acute and chronic
malnutrition are major problems for HIV-positive children
living in resource-limited settings. Malnutrition on a
background of HIV represents a separate clinical entity,
with unique medical and social aetiological factors.
Children with HIV have a higher daily calorie
requirement than HIV-negative peers and also a higher
requirement for micronutrients; furthermore, coinfection
and chronic diarrhoea due to HIV enteropathy play a
major role in HIV-associated malnutrition. Contributory
factors include late presentation to medical services,
unavailability of antiretroviral therapy, other issues
surrounding healthcare provision and food insecurity in
HIV-positive households. Treatment protocols for
malnutrition have been greatly improved, yet there
remains a discrepancy in mortality between HIV-positive
and HIV-negative children. In this review, the aetiology,
prevention and treatment of malnutrition in HIV-positive
children are examined, with particular focus on resource-
limited settings where this problem is most prevalent.
BACKGROUND
Infection with HIV is one of the greatest challenges
to global health faced by the medical profession.
There are 3.4 million HIV-positive children under
15 years of age and 340 000–450 000 new infec-
tions in the paediatric population each year.
1 HIV
infection is particularly aggressive in children—
without access to treatment, more than half of
HIV-infected infants die before the age of 2 years,
with a median survival of only 23 months.
2
Malnutrition affects over one-quarter of under
5s in the developing world and is thought to con-
tribute to one-third of deaths in this age group—
estimated at 1–2 million deaths per year.
3 The
majority of low-income countries (with the highest
rates of malnutrition) have insufﬁcient death certiﬁ-
cation, so this ﬁgure might be an underestimate.
4
HIV infection and malnutrition often coexist, and
the two conditions overlap and interact. Prevalence
of concurrent HIV infection in children presenting
with severe acute malnutrition (SAM) is variable,
with ﬁgures of up to 71.8% reported.
28
Meta-analysis of 17 large studies in sub-Saharan
Africa suggested that 29.2% of children presenting
with SAM were HIV-positive, although given the
higher prevalence of HIV in this region, this might
not be globally representative.
5 Importantly, mor-
tality from SAM is more than three times higher in
HIV-positive children than their HIV-negative
peers.
5
SAM is deﬁned by the WHO as a
weight-for-height z-score of less than –3, or a mid-
upper arm circumference of less than 11.5 cm in chil-
dren aged 6 months to 5 years.
6 SAM can present as
non-oedematous (marasmus) or oedematous disease
(kwashiorkor or marasmic-kwashiorkor), with maras-
mus being more common in HIV-positive children.
67
In addition, HIV-positive children with SAM are at
higher risk of infectious comorbidities (such as tuber-
culosis, respiratory tract infections, gastroenteritis
and candidiasis) and other complications (such as
persistent diarrhoea and poor oral intake).
This article sets out to discuss the aetiology of
increased risk of malnutrition in HIV-positive chil-
dren from both a medical and social viewpoint. It
also aims to discuss management guidelines for this
complex condition and preventive measures.
AETIOLOGY OF DISEASE: MEDICAL
HIV-positive children have greater nutritional
needs
When compared with HIV-negative counterparts,
HIV-infected children (including asymptomatic
children) have additional nutritional requirements
to ensure normal growth and development and
require high-energy, high-protein, nutrient-dense
diets.
8 Calorie intake needs to be increased, with
children requiring up to 150% of the recom-
mended daily allowance of calories, and micronu-
trient requirement is up to ﬁve times that of an
HIV-negative child (table 1).
8 It is recommended
that—compared with HIV-negative children—
asymptomatic HIV-positive children have a 10%
increased calorie intake, which is best given
through additional household foods, as part of a
balanced, varied diet. HIV-positive children with
chronic lung disease, chronic TB or chronic diar-
rhoea require approximately 20–30% increased
calorie intake, which might be provided through
increased household foods or through nutritional
supplementation. Children with severe complica-
tions of HIV infection, such as SAM or stunted
growth, require 50–100% increased energy intake
each day, until weight is recovered. These increased
nutritional demands reﬂect the increased nutrient
cost of immune system support and prevention of
muscle wasting. In resource-limited settings (RLS)
where food availability is limited, it is clear that the
increased nutritional requirements are unlikely to
be met.
Diarrhoea and other infections
Acute, recurrent and chronic diarrhoea, and subse-
quent malabsorption, are common in HIV-positive
children. Common infective organisms include bac-
teria (eg, salmonella, shigella, campylobacter),
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amoeba, giardia, cryptosporidia) and fungi (eg, candida, histo-
plasma). Recurrent and chronic diarrhoea are, understandably,
risk factors for the development of SAM and growth
impairment.
Furthermore, malnutrition predisposes to gastrointestinal tract
infection through gut mucosal barrier dysfunction, establishing
a vicious infection-malnutrition cycle. Other infections—par-
ticularly pneumonia, which is also very common in
HIV-positive children—have been found to contribute to the
increased risk of malnutrition in children in several lower-
income countries.
9
Coinfection with HIVand Mycobacterium tuberculosis (TB) is
an extremely common problem: TB is the largest single cause of
death in HIV-positive individuals and, in areas of high preva-
lence, it is the most common coinfection in HIV-positive chil-
dren.
10–12 HIV and TB pathogens interact, resulting in an
accelerated clinical course and premature death. TB infection
results in secondary wasting: indeed, weight loss is the present-
ing feature in almost 50% of cases of TB and persistent anorexia
is a feature in approximately one-quarter.
13 Weight loss asso-
ciated with TB is particularly marked in RLS. For example, in
Malawi, TB patients had signiﬁcantly lower body fat mass (35%
lower) and 19% less lean body mass than matched controls, the
extent of wasting being related to severity of TB infection.
14
Furthermore, malnutrition is a risk factor for the acquisition of
primary TB infection, as well as progression to active disease.
HIV enteropathy
HIV enteropathy is a unique disease entity caused by direct
HIV-mediated and indirect cytokine-mediated damage to the
gastrointestinal mucosa in the absence of pathogens. It can
affect individuals at all stages of HIV infection and is charac-
terised by chronic diarrhoea, gastrointestinal inﬂammation,
increased intestinal permeability and malabsorption. HIV enter-
opathy causes typical histological changes, including lympho-
cytic inﬁltration of the epithelium, villous atrophy/blunting and
crypt hyperplasia.
15 Chronic diarrhoea and malabsorption
caused by HIV enteropathy lead to malnutrition, which
increases the risk of infective gastroenteritis; the interacting
effects of infection and HIV enteropathy drive a vicious cycle
that propagates malnutrition.
16
Late presentation to medical services
In RLS, presentation to hospital for SAM—and other conditions—
is often very late, with consequent poorer outcomes of medical
intervention.
17 In HIV-positive children, it has been observed that
many SAM-related deaths occur within 1 week of admission, indi-
cating the advanced stage of disease.
18 The reasons underlying late
presentation are complex and involve social, economic and cultural
barriers, but it is likely that late presentation contributes signiﬁcantly
to the excess mortality seen in HIV- i n f e c t e dc h i l d r e nw i t hS A M .
AETIOLOGY OF DISEASE: SOCIAL
Wasting and malnutrition in HIV-positive children does not
simply reﬂect interactions of biological processes, but includes a
series of failures within the health system, the home and
community.
8
Food insecurity in HIV-positive households
Food security is deﬁned as regular physical, social and economic
access to sufﬁcient quantities of safe and nutritious food, which
meets the dietary requirements for a healthy life. When these
conditions are not met, food insecurity is said to exist. A com-
bination of reduced earnings due to frailty, reduced savings and
assets, the high cost of antiretroviral treatment (ART) and high
adult mortality causes food insecurity in HIV households. Food
insecurity increases the risk of malnutrition in children in the
household. However, employment and income among
HIV-positive people increases after prolonged ART treatment,
thus improving food security and nutritional status of all house-
hold members.
19 20 A study of 30 000 HIV-positive people
showed that treatment with ARTresulted in recovery of employ-
ment to 90% of baseline compared with 37% before treatment
was initiated.
19
Children born to HIV-positive mothers not receiving ART
have 2.5 times higher risk of dying before their second birthday
than children of HIV-negative women, malnutrition being one
contributing factor.
21 In the developing world, women are the
main caregivers and food purchasers/preparers in the family
and, therefore, maternal illness from HIV contributes to malnu-
trition in children. Timely initiation of ART in HIV mothers
has, however, been shown to reduce under ﬁve mortality rates
to levels similar to those of children of HIV-negative women.
22
A large study in rural South Africa demonstrated that the under
2s mortality rate fell signiﬁcantly following the initiation of
maternal ART—this being the most important contributing
factor to the decline in paediatric mortality.
23 It is clear, there-
fore, through the effects of food security and maternal HIV that
all children in HIV-positive households are at greater risk of
malnutrition than children in households where neither parent
has HIV/AIDS.
Barriers to accessing healthcare
A major contribution to the excess mortality due to malnutri-
tion in HIV-positive children is the inaccessibility of timely and
appropriate medical services. The barriers to access of medical
care are plentiful and vary on regional, country and district
levels.
There is a paucity of hospitals and healthcare facilities in
poorer countries, meaning that distances that individuals must
travel to access healthcare can be great. Distance and transport
are reported as the major barriers to accessing maternal and
paediatric health services in many developing countries.
24 25 In
addition to the cost of transport, a major ﬁnancial barrier to
treatment for both HIV and malnutrition is the cost of medical
Table 1 Daily calorie requirements of HIV-positive children
Daily calorie requirement (kcal/day)
Age HIV-negative
HIV-positive
(asymptomatic)
HIV-positive
with poor
weight gain
or other
complications
HIV-positive
with severe
complications
6–11
months
690 760 830 150–220
12–23
months
900 990 1080 150–220
2–5
years
1260 1390 1510 150–220
6–9
years
1650 1815 1980 75–100
10–14
years
2020 2220 2420 60–90
Data taken from WHO Guidelines.
8
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this can ostracise the poorest in the community.
Although there are relatively few good studies into the effects
of stigma on HIV-positive individuals, it is accepted that stigma
is ubiquitous to people living with HIV/AIDS (PLWHA) and this
offers a constant barrier to treatment. Efforts to reduce preju-
dice and discrimination in health workers involved in HIV man-
agement, as a mode to reduce stigma, have been met with
unremarkable results.
26
Suspicions and fear surrounding ‘Western’ medicine and
health interventions have been reported in Zambia and repre-
sent another barrier to healthcare provision to HIV-positive
children.
27 Fear of Western science and medicine has also been
observed in clinical trials from across the developing world and
is indicative of a far greater and complex problem that impacts
on management of malnutrition in HIV-positive children.
28 The
roots of this have been mooted from many different anthropo-
logical, political and sociological approaches, discussion of
which is beyond the scope of this article.
PREVENTION AND TREATMENT OF MALNUTRITION IN
HIV-POSITIVE CHILDREN
Best practice in infant feeding
A safe and effective infant feeding regimen that minimises the
risk of HIV transmission needs to be implemented in all children
born to HIV-positive mothers. Where infection has already
occurred, best practice feeding regimens reduce the risk of
HIV-associated malnutrition. It is estimated that up to 40% of
cases of vertical transmission in sub-Saharan Africa have occurred
via breast feeding.
29 The feeding of a child born to an
HIV-positive mother must be analysed on an individual and con-
textual basis, following published guidelines (table 2). Overall,
e x c l u s i v eb r e a s tf e e d i n gf o rt h eﬁrst 6 months is recommended
for HIV-positive mothers unless replacement feeding is accept-
able, feasible, affordable, sustainable and safe (AFASS, ﬁgure 1).
30
Treatment with ART minimises the risk of vertical transmission.
It is imperative that mixed feeding (ie, part breast; part
formula or semisolid foods) is avoided in the ﬁrst 6 months of
life; this is particularly crucial when ART is unavailable or
unacceptable to the mother. In children under 6 months, a
mixed feeding regimen of breastmilk and formula milk resulted
in an approximately twofold increased risk of vertical transmis-
sion of HIV , while mixed feeding with solids increased the risk
to 11-fold.
31–34 Vertical transmission of HIV occurs when virus
present in the milk infects children through the intestinal
mucosa. It has been suggested that the use of formula milk and/
or solid foods interferes with the integrity of the infant intes-
tinal mucosa, thereby increasing the risk of vertical transmis-
sion.
31 35 On the other hand, cessation of breast feeding before
6 months has been implicated in increased infant mortality,
especially from diarrhoea.
36 In high HIVendemic areas, there is
emerging evidence that feeding practices differ signiﬁcantly
from these recommendations. In South Africa, for example, less
than 8% of infants under 6 months old are exclusively breast
fed.
37
Education regarding prevention of HIV transmission and
optimal infant feeding regimens are crucial for the prevention
of malnutrition. Infant feeding and nutrition has been identiﬁed
as a major concern for women living in RLS, which suggests
that women would be receptive to such education pro-
grammes.
38 It is particularly helpful if the female educator is a
positive role model, whose own children are thriving despite
also living in poor conditions, as this has a signiﬁcant and
lasting effect on the rates of recovery from malnutrition in both
rural and urban settings in developing countries around the
world, including South Africa, Bangladesh and Haiti.
39 40
Treatment of SAM
When preventative strategies fail, either community-based or
hospital-based therapies need to be implemented to prevent
mortality from SAM. The community-based approach involves
provision of treatment for those without medical complications
with ready-to-use therapeutic foods (RUTFs) or other nutrient-
dense foods at home. Hospital or special facility-based
approaches are required for severely malnourished HIV-positive
children with medical complications, including children with
reduced appetite or coexisting infections.
The treatment regimen for SAM of HIV-infected children
should follow the WHO guidelines.
41 It involves initial stabilisa-
tion of the child, followed by a rehabilitation phase. During the
initial stabilisation phase, life-threatening problems are identiﬁed
and treated, with the aim of reducing oedema and restoring
organ function.
41 42 Key steps include treatment of infections,
caloric replacement (such as F75, discussed later) sufﬁcient to
prevent loss of further muscle and fat and correction of electro-
lyte imbalance. Treatment of acute infection during the
Table 2 Best practice infant feeding regimens for children born to
HIV-positive mothers, based on WHO guidelines
52–53
Age group
(months)
Recommended management for feeding children born
to HIV-positive mothers
0–6 Exclusive breast feeding, unless replacement feeding is
AFASS
If replacement feeding is AFASS, then breast feeding should
be avoided
6–8 If replacement feeding is not AFASS, continue with breast
feeding and introduce complementary alternative foodstuffs
Alternative foods should be fortified with supplements if
animal food sources are not available
Food should be of a pureed or mashed consistency.
AFASS situation should be constantly assessed
9–11 As above but with more solid foods, or so-called ‘finger
foods’
12–23 In general, children can eat the same meals as family
members
Daily calorie requirements of children depend on HIV clinical status and can be seen
in table 1.
AFASS, acceptable, feasible, affordable, sustainable and safe.
Figure 1 Infants under the age of 6 months born to HIV-positive
mothers should be exclusively breast fed unless breast milk substitutes
fulﬁl the acceptable, feasible, affordable, sustainable and safe criteria,
as deﬁned by the Joint United Nations Programme on HIV/AIDS.
36
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such as gastroenteritis, malaria, pneumonia, bacteraemia (30%)
and other invasive bacterial diseases complicate a large propor-
tion of early deaths in children admitted for SAM.
42
Treatment of TB infection is a crucial step in treatment of
SAM as it in itself can cause signiﬁcant wasting. A further infec-
tion that warrants particular attention is oesophageal candidia-
sis, which affects approximately 10% of HIV-positive
individuals at some point.
43 Oesophageal candidiasis causes dys-
phagia and odynophagia, which can lead to poor oral intake
and subsequent wasting, and, as such, treatment of any concur-
rent oral or oesophageal candida infection is an important part
of treatment of SAM.
The rehabilitation phase involves gradual introduction of
foods, use of high-calorie nutritional formulas (such as F75,
F100) and micronutrient/vitamin supplementation. The rehabili-
tation phase primarily comprises 6–10 weeks of therapeutic
feeding with 50–100% increased calorie intake, as well as holis-
tic assessment of the child’s health, HIV therapy and family
setting (table 1, ﬁgure 2). Alternatively, for children with
uncomplicated malnutrition, community or outpatient-based
treatment with RUTF can be initiated. The major beneﬁto f
RUTF is that it addresses the major problem of lack of access to
inpatient facilities and allows timely intervention.
There has been some controversy surrounding the efﬁcacy of
malnutrition treatment regimens in HIV-positive children, with
mortality remaining approximately three times higher in
HIV-positive children than HIV-negative children, regardless of
treatment setting.
5 The excess mortality observed is likely to be
due to concurrent infections and other medical complications of
HIV infection. Surprisingly, meta-analysis showed that mortality
rates among HIV-positive children in hospital settings compared
with those receiving community-based treatment were identi-
cal.
5 These data will need to be re-evaluated once there has
been widespread implementation of the guidelines speciﬁct o
HIV-positive children. It is hoped that these guidelines will
reduce the discrepancy in mortality between HIV-positive and
HIV-negative children.
Correct timing of initiation of ART
In recent years, there has been a dramatic increase in the pro-
portion of HIV-positive individuals on treatment: for example,
in one hyperendemic region in Southern Africa, since the ART
programme ‘scale-up’, there has been an increase from 0% in
2004 to 31% in 2011.
44 Use of ART has led to a decrease in
morbidity and mortality in HIV-positive children in RLS.
Despite widespread advances in the availability of ART, there
remains a disparity between the number of children who require
ART and the number receiving treatment; furthermore, initi-
ation of therapy occurs late in children with already advanced
disease.
5 Initiation of ART is associated with a sustained
improvement in growth responses, especially in younger
Figure 2 Guidelines for treatment of severe malnutrition in HIV-positive children, based on WHO guidelines.
84 1Although early initiation of
antiretroviral treatment is advocated in these guidelines, this remains controversial, and delaying initiation of treatment until after the acute phase
might be prudent.
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45–47
The direct effect of ARTon growth, as well as the decreased fre-
quency of opportunistic infections in children receiving ART,
means that absence (or late initiation) of ART treatment can be
considered a risk factor for development of malnutrition in
HIV-positive children.
This is a controversial area as there have been several reports
showing that severe malnutrition was precipitated in the months
following ART initiation.
48 49 One study reported that approxi-
mately 10% of HIV-positive children were hospitalised for
severe malnutrition within 12 weeks of starting ART.
48
Furthermore, an unusually large proportion of these children
developed oedematous malnutrition (kwashiorkor), and it has
been argued that this is because a degree of immune compe-
tence is required to develop oedema.
50
It was postulated that the SAM observed might represent a
form of immune reconstitution syndrome (IRIS) in children
with underlying chronic malnutrition and severe immunosup-
pression.
48 This is supported by a large study in Peru of children
initiating ART, where children with IRIS were more likely to
develop one or more indicator(s) of malnutrition compared
with children without IRIS, this effect being more signiﬁcant in
children under 5 years of age.
51 Another plausible explanation
is that the development of malnutrition following initiation of
ART represents a variant of re-feeding syndrome or an unusual
antiretroviral toxicity reaction.
48
Further research is required to establish the pathogenesis of
this phenomenon and to determine the optimal time of ART
initiation in children with underlying malnutrition in order to
avoid rebound complications. Until there are clear evidence-
based guidelines, it would seem prudent to treat SAM and acute
medical problems with initiation of ART once the child is
stabilised.
CONCLUSIONS
Malnutrition is a major threat to the health of children living in
RLS and is responsible for up to 2 million deaths per year in
children under 5 years of age. Malnutrition on a background of
HIV infection is a complex medical condition that carries sig-
niﬁcant morbidity and mortality for affected children, with
greater mortality from SAM among HIV-positive children than
their HIV-negative peers. It is crucial that research continues
into the pathogenesis of SAM on a background of HIV infection
as this will allow the establishment of more effective care path-
ways for complicated SAM, thereby decreasing the disparity in
mortality between HIV-positive and HIV-negative children.
Furthermore, given that there is high HIV prevalence among
children with SAM, HIV testing should be considered in all chil-
dren from high-risk areas who present with SAM.
Prevention of mother-to-child transmission of HIV remains
one of the most important interventions to improve global child
health. In particular, an increase in exclusive breastfeeding rates
would lead to decreased vertical transmission. Education and
support for mothers of HIV-positive children is crucial, espe-
cially with regards to infant breastfeeding practices. Support
should also be given to help meet the increased daily nutritional
needs of HIV-infected children in order to prevent development
of SAM. Government-level interventions to improve healthcare
infrastructure and assure food security are other important steps
in the prevention of malnutrition in HIV-positive children.
Coinfection is another major contributor to SAM in
HIV-positive children, and efforts to reduce number of infec-
tions, such as gastroenteritis (eg, through water sanitation), are
important. Given the complex and detrimental interaction
between HIV , TB and malnutrition, the global ﬁght against
mycobacterial infection must continue, and a decrease in TB
incidence might improve nutrition among HIV-positive chil-
dren. Finally, although it is clearly beneﬁcial to start
HIV-positive children on ART, the question of when this
therapy should be initiated in children with SAM needs to be
addressed. Further research needs to be conducted into the
correct timing of therapy in order to maximise the beneﬁts of
treatment while minimising the risk of rebound malnutrition.
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